There's little doubt that isonea is in a sector that is emerging...

There's little doubt that isonea is in a sector that is emerging and gathering pace ... the real challenge is to convince caregivers that their patients will benefit from increased monitoring and (more particularly) isonea's products.

I've no doubt that this is management's main aim in the year ahead. Am very comfortable with where isonea is sitting share price wise and i fully expect that as more detail is revealed about the pipeline of products, the commercial strategy and the takeup that this stock will have another big push towards the $1+ region. This is holding up well after a huge run.

Isonea is in the market and grafting out an innings. To take the cricketing parlance a little further, I'd say we are getting our eye in around the 20s in a bid to mbuild a solid base. Once that work is done the big shots will blast us past the ton.